Erschienen in:
18.09.2019 | Editorial
A big step towards clinical implementation of myocardial blood flow quantification with CZT SPECT
verfasst von:
Matthieu Pelletier-Galarneau, MD, MSc, Terrence D. Ruddy, MD
Erschienen in:
Journal of Nuclear Cardiology
|
Ausgabe 4/2021
Einloggen, um Zugang zu erhalten
Excerpt
One of the main benefits of positron emission tomography (PET) myocardial perfusion imaging (MPI) over other imaging techniques is its ability to perform accurate myocardial blood flow (MBF) quantification.
1 Quantification of MBF has been shown to increase diagnostic performance of PET MPI,
2‐
4 an increase attributed in part to improved detection of multivessel disease and identification of sub-optimal response to pharmacological stress.
1,
4,
5 In addition, integration of flow quantification with PET MPI leads to better risk stratification of patients with coronary artery disease, as demonstrated by a significant increase of major cardiovascular events and deaths in patients with reduced myocardial flow reserve (MFR), even in the absence of inducible ischemia or scar on perfusion imaging.
6,
7 Moreover, the prognostic value of flow quantification has been established in various populations, such as patients with diabetes
8 and kidney failure,
9,
10 as well as in several non-ischemic cardiomyopathies.
11 …